IFIH1 and autoimmune polyendocrinopathy: However, the treatment of APS caused a mild increase in the activity of the expression of MDA5 (p < 0.05) and the expression of MDA5 in the anti-MDA5 mAb group showed nonsignificance with the control group (p > 0.05).